Johnson & Johnson issued the following announcement on Aug. 8.
Johnson & Johnson (NYSE: JNJ) announced the appointment of Chris DelOrefice to Vice President of Investor Relations for Johnson & Johnson, effective August 13, 2018. Mr. DelOrefice will report to Mr. Joseph Wolk, Executive Vice President and Chief Financial Officer of the Company.
Mr. DelOrefice has been with Johnson & Johnson for 19 years and has most recently served as the CFO of the North America Hospital Medical Devices (MD) Business. In this role, he provided strategic financial leadership and counsel, which were integral in evolving the MD portfolio and commercial strategy to support our long-term growth. Previously, Mr. DelOrefice held various leadership positions across all three segments of Johnson & Johnson and many functions of the Company, and was instrumental in leading key mergers and acquisitions, negotiating critical licensing and managed care agreements and implementing major business restructurings.
"Chris is an accomplished leader, with a long track record of success. He consistently demonstrates Credo values and will continue to have a positive impact on Johnson & Johnson's financial strength and stability and on the development of our future business leaders," Mr. Wolk said.
Mr. DelOrefice holds a Bachelor of Science and MBA from Villanova University, and received his CPA certification from the Commonwealth of PA.
Original source can be found here.